Research Streams
03 — Growth Axis Research
Growth hormone releasing peptides, secretagogues, and growth pathway modulators
Growth hormone secretagogues and GHRH analogues stimulate pulsatile release of growth hormone from the anterior pituitary. Multiple compounds in this class have progressed through clinical development and are studied for GH axis modulation in laboratory settings. These research tools enable investigation of the somatotropic axis and downstream insulin-like growth factor signalling.
Growth Axis Research
CJC-1295 / Ipamorelin
$99 AUD In Stock
A dual-peptide research stack combining a growth hormone-releasing hormone (GHRH) analogue with a selective GH secretagogue. CJC-1295 extends the half-life of GHRH signalling while Ipamorelin stimulates GH release through the ghrelin receptor without affecting cortisol or prolactin.
Growth Axis Research
Tesamorelin
$130 AUD In Stock
A synthetic analogue of growth hormone-releasing hormone (GHRH). Tesamorelin is a regulatory-approved GHRH analogue studied extensively for its role in growth hormone pathway research and body composition investigations.
For detailed research data and mechanism analysis, visit our blog (coming soon).
All products are research compounds intended for laboratory research use only. Not for human or veterinary use. Kinetic Labs does not provide dosing guidance, therapeutic recommendations, or medical advice of any kind.